Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

NCT02631252 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Inability to accrue

Conditions

Leukemia, Acute Myelogenous

Interventions

DRUG: Hydroxychloroquine
DRUG: Mitoxantrone
DRUG: Etoposide

Sponsor

Alison Sehgal, MD, MS